Hepatectomy for liver metastases from gastric cancer: a systematic review

about

Intensified neoadjuvant multimodal approach in synchronous liver metastases from gastric cancer: a single institutional experience.

P2860

Q48171739-2E567F00-8C6F-49C9-9DCA-B65EF1A89E02

P2860

Hepatectomy for liver metastases from gastric cancer: a systematic review

Item

http://www.wikidata.org/entity/Q36279153

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Hepatectomy for liver metastases from gastric cancer: a systematic review

@ast

Hepatectomy for liver metastases from gastric cancer: a systematic review

@en

type

Item

label

Hepatectomy for liver metastases from gastric cancer: a systematic review

@ast

Hepatectomy for liver metastases from gastric cancer: a systematic review

@en

prefLabel

Hepatectomy for liver metastases from gastric cancer: a systematic review

@ast

Hepatectomy for liver metastases from gastric cancer: a systematic review

@en

P1476

Hepatectomy for liver metastases from gastric cancer: a systematic review

@en

P2093

Di Long

http://www.w3.org/2001/XMLSchema#string

Le-Qun Li

http://www.w3.org/2001/XMLSchema#string

Ning-Fu Peng

http://www.w3.org/2001/XMLSchema#string

Peng-Cheng Yu

http://www.w3.org/2001/XMLSchema#string

Sen Zhang

http://www.w3.org/2001/XMLSchema#string

Ying-Yang Liao

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Surgery for Liver Metastases From Gastric Cancer: A Meta-Analysis of Observational Studies

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Assessing heterogeneity in meta-analysis: Q statistic or I2 index?

Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer.

Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases.

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile?

Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion.

P2888

s12893-017-0215-0

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12893-017-0215-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jian-Hong Zhong

P5008

ScienceSource

P577

2017-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083812309

http://www.w3.org/2001/XMLSchema#string

P698

28193210

http://www.w3.org/2001/XMLSchema#string

P921

P932

5307809

http://www.w3.org/2001/XMLSchema#string

Hepatectomy for liver metastases from gastric cancer: a systematic review

about

P2860

P2860

Hepatectomy for liver metastases from gastric cancer: a systematic review

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P6179

P698

P921

P932